secwatch.observer — SEC 8-K summary
======================================

Issuer:     SAFEGUARD SCIENTIFICS INC (SFES)
CIK:        0000086115
Form:       8-K
Filed at:   2023-03-09T23:59:59+00:00
Accession:  0001437749-23-005972
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Safeguard Scientifics posts FY2022 net loss of $14.3M vs net income of $27.0M in 2021
--------------------------------------------------------------------------------

- Net loss Q4 2022 $4.9M ($0.30/share) vs loss $8.6M ($0.51) in Q4 2021; FY2022 net loss $14.3M ($0.87) vs net income $27.0M ($1.36) in FY2021.
- Cash & securities $19.3M at Dec 31, 2022; carrying value of ownership interests $15.4M.
- Annual deployments $5.7M within prior guidance of $5M-$9M; funded loans to meQuilibrium and Trice Medical.
- Repurchased 711,481 shares for $2.9M in 2022 at avg $4.13; added 736,577 shares through Jan 2023 under $3M plan.
- Operating costs down 33% YoY: G&A $4.8M in 2022 vs $7.2M in 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/86115/000143774923005972/0001437749-23-005972-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/86115/000143774923005972/sfe20230308_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-005972

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer